pharma · Breast Cancer · Prostate Cancer · UTHR
United Therapeutics Europe
United Therapeutics Europe Ltd
United Therapeutics is a pharma organization headquartered in Silver Spring, USA. It trades on NYSE under ticker UTHR. Primary therapeutic focus areas include Breast Cancer, Prostate Cancer, Pulmonary Arterial Hypertensi
1000 Spring Street, Silver Spring, Maryland 20910, US HQ
1996 Founded
1,443 Employees
Public company Type
UTHR · NYSE Ticker
Company details
- Status
- Public
- HQ
- 1000 Spring Street, Silver Spring, Maryland 20910, US
- Founded
- 1996
- Employees
- 1,443
- Programs
- 1032
- Drugs
- 612
- Patents
- 3720
Brentuximab Vedotin
Phase 2 · small molecule · Ann Arbor Stage IB Hodgkin Lymphoma
Brentuximab Vedotin for Ann Arbor Stage IB Hodgkin Lymphoma is a Phase 2 program (small_molecule) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).
Internal code RU051505I
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- United Therapeutics Europe Ltd
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Ann Arbor Stage IB Hodgkin Lymphoma
- Status
- active
- Trials
- 1